Coronavirus highlights the $35 billion vaccine market. Here are the key players

  • 📰 CNBC
  • ⏱ Reading Time:
  • 27 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 72%

Россия Новости Новости

Россия Последние новости,Россия Последние новости

New for subscribers: Coronavirus highlights the $35 billion vaccine market. Here are the key players Check out CNBCPro and get your first 30 days free.

"For every dollar invested in vaccination in the world's 94 lowest-income countries, the net return is $44. Hard to argue against," Wimal Kapadia, Bernstein's analyst, said in a note. "This oligopoly has been built through significant market consolidation driven primarily by the complexities of the manufacturing and supply chain."

Sanofi is teaming up with the U.S. government to develop a vaccine for the new virus, hoping its work on the 2003 SARS outbreak could speed up the process. GlaxoSmithKline said this month it is partnering with the Coalition for Epidemic Preparedness Innovations for a vaccine program. Its human papillomavirus vaccine Gardasil 9 will be "the biggest selling vaccine of all time," Kapadia said. "Gardasil 9 will take over the HPV market given competition is limited - supply is the only decelerator."

 

Спасибо за ваш комментарий. Ваш комментарий будет опубликован после проверки
Мы обобщили эту новость, чтобы вы могли ее быстро прочитать.Если новость вам интересна, вы можете прочитать полный текст здесь Прочитайте больше:

 /  🏆 12. in RU

Россия Последние новости, Россия Последние новости

Similar News:Вы также можете прочитать подобные новости, которые мы собрали из других источников новостей

Stock market live updates: Dow futures down 770, airlines slide, Apple dropsStock market live updates: Gold futures gained more than 2% to around $1,680 per ounce, reaching its highest level since Jan. 23, 2013. top
Источник: CNBC - 🏆 12. / 72 Прочитайте больше »